Actively Recruiting
Sexual Dysfunction in Hypertensive Women
Led by University Hospital, Toulouse · Updated on 2024-10-23
348
Participants Needed
1
Research Sites
210 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Several studies describe the existence of an association between sexual dysfunction and high blood pressure (hypertension), most often characterized by a decrease in the number of orgasms and the existence of dyspareunia. Hypertension is a contributing factor, and nonadherence to medication could amplify it. There are several ways to assess adherence to treatment: the use of declarative questionnaires, a method not without criticism because it is subject to the subjectivity of the declaration by the patient; and drug dosages, a standard technique, although insufficiently disseminated due to the high cost and greater weight of the survey protocols. Drug non-compliance is multifactorial. In addition, it has been shown that having undesirable drug effects and / or being afraid of developing them is one of the major causes of non-compliance with antihypertensive treatments. The investigators hypothesize that DS is significantly more common among hypertensive women treated with non-observers compared to hypertensive women treated with observers. The main objective is to compare the prevalence of sexual dysfunction between a group of hypertensive women treated as observers and a group of hypertensive women treated as non-observers.
CONDITIONS
Official Title
Sexual Dysfunction in Hypertensive Women
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women over 18 years old
- Hospitalized or seen in consultation for hypertension management in participating nephrology, cardiology, or hypertension departments
- Confirmed hypertension treated with at least one of the specified dosable antihypertensive agents
- Signed informed consent form
- Beneficiary or affiliated with French Social Insurance
You will not qualify if you...
- Patients who have had bariatric surgery
- Patients under guardianship, trusteeship, or legal protection
- Patients diagnosed and treated for psychosis or depression
- Pregnant or nursing women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
LAZARO Delphine
Toulouse, CHU de Toulouse, France, 31059
Actively Recruiting
Research Team
D
Delphine LAZARO-VERGE
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here